B+
Bull case
20%
Probability
Target price
$9.50
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
NERV
Minerva NeurosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Minerva has an ongoing confirmatory Phase 3 program, a stated 2H 2027 efficacy-data target, FDA design discussions, and a large unmet-need positioning for roluperidone. A successful readout could support substantial upside [#SEC-8K-2026-08-07].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Analyst revisions, consensus surprise data, and verified post-earnings market attribution are unavailable.
Momentum
86
Value
41
Sentiment
69
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.90 · Bull $9.50 · Bear $1.50Analysis 2026-08-07; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-07 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $10.33
Why
Momentum86 · Δ7d -
Value41 · Δ7d 0.0
Sentiment69 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Analyst revisions, consensus surprise data, and verified post-earnings market attribution are unavailable.
- • Higher R&D and G&A spending may accelerate cash burn and financing or dilution risk.
- • The thesis remains dependent on one late-stage asset and a binary clinical outcome.
Catalyst clock
2026-08-07
Higher clinical-development spending increases runway and dilution sensitivity
Lead driver: Sentiment · See AI snapshot
Momentum
86
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
69
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 85.6 / Value 41.2 / Sentiment 69.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-07. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$3.90
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$1.50
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$211.04M
Beta
-0.24
Shares Out
47.75M
P/E (TTM)
2.7
P/S (TTM)
-
P/FCF (TTM) · Derived
-4.09
Rev YoY
-100.0%
EPS YoY
-68.0%
Gross Margin
-
Op Margin
-
Net Debt
-$17.44M
Current Ratio
20.14
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data